Glycoprotein P pharmacogenetic assessment role in digoxin pharmacotherapy individualization: a new approach for an old problem
The aim of the study was to investigate effects of glycoprotein P-coding gene MDR1 polymorphic marker C3435T on digitalis intoxication symptoms and plasma digoxin concentration increase in patient with persistent atrial fibrillation (AF). In 103 AF patients, genotyping by gene MDR1 polymorphic marke...
Saved in:
Main Authors: | D. A. Sychev, I. V. Ignatiev, D. A. Andreev, L. G. Poshukaeva, P. V. Kolkhir, E. E. Zhukova, V. G. Kukes |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2006-08-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1937 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digoxin toxicity with therapeutic serum digoxin concentrations
by: J. Graafsma, et al.
Published: (2025-12-01) -
MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01) -
Role of P-glycoprotein in the pharmacotherapy of pregnant women
by: N. M. Popova, et al.
Published: (2019-07-01) -
THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY
by: A. V. Shulkin, et al.
Published: (2015-09-01) -
OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01)